<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02450110</url>
  </required_header>
  <id_info>
    <org_study_id>RAPID-HELP</org_study_id>
    <nct_id>NCT02450110</nct_id>
  </id_info>
  <brief_title>A Pilot Study of Spinal Cord Stimulation in Heart Failure Patients With Depressed Left Ventricular Function</brief_title>
  <acronym>RAPID-HELP</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health</source>
  <brief_summary>
    <textblock>
      A randomized pilot study of spinal cord stimulation in patients with chronic heart failure
      aiming to show whether this therapy impacts central haemodynamic and autonomic regulations.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be randomized (1:1) for spinal cord stimulation as an addition to optimal
      guidelines-driven management or to control group on optimal management only. Spinal cord
      stimulation will be performed for 30 days, and outcome measures will be testes before
      stimulation, after 30 days stimulation and after 30 days of further follow-up. The control
      group will be studied at baseline and after 30 days only.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>February 2015</start_date>
  <completion_date type="Anticipated">October 2017</completion_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Dynamics of NT-pro-BNP-level</measure>
    <time_frame>Baseline, 30, 60 days</time_frame>
    <description>NT-pro-BNP-level baseline, 30 days and 60 days (intervention) NT-pro-BNP-level baseline, 30 days (control)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Exercise capacity as determined by a cardiopulmonary test</measure>
    <time_frame>Baseline, 30, 60 days</time_frame>
    <description>Exercise capacity (cardiopulmonary test) baseline, 30 days and 60 days (intervention) Exercise capacity (cardiopulmonary test) baseline, 30 days (control)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in heart failure functional class</measure>
    <time_frame>Baseline, 30, 60 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in atrial effective refractory period</measure>
    <time_frame>Baseline, 30, 60 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with ventricular arrhythmias</measure>
    <time_frame>Baseline, 30, 60 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Autonomic regulation tests results change</measure>
    <time_frame>Baseline, 30, 60 days</time_frame>
    <description>Tilt-test, Valsalva maneuver, deep breath test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Levels of pro-inflammatory plasma markers</measure>
    <time_frame>Baseline, 30, 60 days</time_frame>
    <description>TNF-a, CRP, fibrinogen</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in left ventricle ejection fraction as determined by echocardiography</measure>
    <time_frame>Baseline, 30, 60 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Left ventricle volume</measure>
    <time_frame>Baseline, 30, 60 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with complications</measure>
    <time_frame>Baseline, 30, 60 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Heart Failure</condition>
  <condition>Systolic Dysfunction</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Spinal cord stimulation on top of standard treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Spinal cord stimulation</intervention_name>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients with chronic heart failure II-III class (NYHA);

          2. Age 18-70 years;

          3. Left ventricle ejection fraction â‰¤35%;

          4. Optimal heart failure management according to the guidelines;

          5. Signed informed consent

        Exclusion Criteria:

          1. Heart transplant list;

          2. Acute conditions, including systemic infection;

          3. Reversible cause of heart failure (thyroid gland diseases, alcoholic intoxication
             etc);

          4. Planned elective heart surgery or intervention;

          5. Recent (3 months) myocardial infarction, coronary intervention;

          6. Heart failure decompensation;

          7. Implanted cardiac resynchronization device &lt; 6 months ago;

          8. Contraindications for lumbal puncture or placement of a spinal cord pacing electrode;

          9. Permanent atrial fibrillation;

         10. Stroke or TIA &lt; 6 months ago;

         11. Pulmonary thromboembolist &lt; 3 months ago;

         12. Hypertrophic cardiomyopathy with obstruction;

         13. Angina III-IV class, or congestive heart failure IV class;

         14. Participation in any other clinical trial;

         15. Women of childbearing possibility without appropriate contraception, pregnant, or
             breastfeeding women.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Evgeny V Shlyakhto, MD, DSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Federal North-West Medical Research Centre</name>
      <address>
        <city>Saint-Petersburg</city>
        <zip>197341</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 12, 2015</study_first_submitted>
  <study_first_submitted_qc>May 18, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 21, 2015</study_first_posted>
  <last_update_submitted>August 10, 2017</last_update_submitted>
  <last_update_submitted_qc>August 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>spinal cord stimulation</keyword>
  <keyword>heart failure</keyword>
  <keyword>autonomic regulation</keyword>
  <keyword>BNP</keyword>
  <keyword>left ventricle systolic dysfunction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

